Industry News

Mar 07, 2014
By BioPharm International Editors
Cobra Biologics and BioCancell announce an agreement to manufacture BioCancell's BC-821 cancer drug.
Mar 07, 2014
By BioPharm International Editors
CPhI report shows R&D market diversifying with increased partnerships, mergers, and revenue sharing models.
Mar 07, 2014
By BioPharm International Editors
Johnson Controls launches Integrated Laboratory Services for R&D facility operations and scientific productivity.
Mar 04, 2014
By BioPharm International Editors
Waters celebrates ten&$45;year anniversary of the ACQUITY UPLC System.
Feb 26, 2014
By BioPharm International Editors
FDA approves the orphan drug Myalept for the treatment of leptin deficiency.
Feb 25, 2014
By BioPharm International Editors
Elanco acquires Germany-based Lohmann Animal Health.
Feb 25, 2014
By BioPharm International Editors
Novartis provides its second US university with Bexsero for the treatment of meningitis B.
Feb 14, 2014
By BioPharm International Editors
Conference sessions, keynote events, exhibits, and poster sessions cover different aspects of bioprocessing.
Feb 13, 2014
By BioPharm International Editors
Debiopharm acquires Affinium's clinical and preclinical assets and its technology platform.
Feb 13, 2014
By BioPharm International Editors
Agilent Technologies and Cell Line Genetics will collaborate on services for regenerative medicine and cancer research.
native1_300x100
lorem ipsum